-

Global Online Movie Ticketing Service Market 2021-2025 by Platform and Region - Projected to Grow by $6.13 Billion due to the Growing Popularity of Box Office and Increased Use of Mobile Applications - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Online Movie Ticketing Service Market 2021-2025" report has been added to ResearchAndMarkets.com's offering.

The global online movie ticketing service market is poised to grow by $6.13 billion during 2021-2025, progressing at a CAGR of 6.25% during the forecast period.

The report on the online movie ticketing service market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment.

The market is driven by the growing popularity of global box office and the increased use of mobile applications. The study identifies the rising number of mobile devices and growing Internet penetration as one of the prime reasons driving the online movie ticketing service market growth during the next few years.

The market is segmented as below:

By Platform

  • Mobile Devices
  • Desktops

By Geographical Landscape

  • North America
  • APAC
  • Europe
  • South America

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading online movie ticketing service market vendors that include:

  • 360 Ticketing
  • Born In Cleveland LLC
  • Carnival Film and Television Ltd.
  • Cinemark Holdings Inc.
  • Comcast Corp.
  • Novo Cinemas
  • PVR Ltd.
  • Tao Piao Piao
  • VUE INTERNATIONAL
  • Wanda Group

Also, the online movie ticketing service market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

For more information about this report visit https://www.researchandmarkets.com/r/va05po

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Industry:

Research and Markets

Release Versions
English

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

South Africa Manufacturing Industry Trends Report 2025: Focus on Food and Beverages, Metal, Petrochemical and Automotive Industries - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Manufacturing Trends in South Africa 2025" report has been added to ResearchAndMarkets.com's offering. This report on trends in the manufacturing sector in South Africa, which is concentrated in the food and beverages, metal, petrochemical and automotive industries, provides information on the size and state of the manufacturing sector including contribution to GDP, performance, employment, production, profitability, trade, tariffs and fixed investment. Investing i...

United States Semaglutide Market Forecast and Company Analysis Report 2025-2033 Featuring Novo Nordisk, Eli Lilly and Co, AstraZeneca, Biocon, Johnson and Johnson, Pfizer, AbbVie, and Sanofi - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "United States Semaglutide Market Report by Product, Application, Distribution Channel, States and Company Analysis, 2025-2033" report has been added to ResearchAndMarkets.com's offering. United States Semaglutide Market is expected to expand from US$ 8.17 Billion in 2024 to US$ 17.29 Billion in 2033 at a Compound Annual Growth Rate (CAGR) of 8.68% during 2025-2033 The growth is fueled by rising awareness regarding obesity control, increasing incidence of diabetes,...

GLP-1 Agonists (Ozempic, Wegovy, Mounjaro) Market - Global Forecast to 2033: Growing Shift of Weekly Injectables Toward Orals and Multi-Agonists - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "GLP-1 Agonists Market by Product (Ozempic, Wegovy, Mounjaro), Molecule (semaglutide, Tirzepatide), Type (Patented, Biosimilars), Format (Single Dose, Multi-dose, Tablets), ROA (SC, Oral), Indication (Diabetes, Obesity) - Global Forecast to 2033" report has been added to ResearchAndMarkets.com's offering. The GLP-1 agonists market is expected to reach USD 170.75 billion in 2033 from USD 64.42 billion in 2025 at a CAGR of 13.0% The report will help market leaders/new...
Back to Newsroom